Jiexian Ma

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Novel model to predict risk of invasive fungal infection and fungal prophylaxis timing.

Novel model to predict risk of invasive fungal infection and fungal prophylaxis timing.

Journal: Microbiology spectrum

Published: October 13, 2025

Advantage of Tolerability following Arsenic Trioxide-VTD vs VRD in newly diagnosed multiple myeloma patients: a prospective, open-label study.

Advantage of Tolerability following Arsenic Trioxide-VTD vs VRD in newly diagnosed multiple myeloma patients: a prospective, open-label study.

Journal: International journal of medical sciences

Published: January 10, 2025

Decitabine with etoposide is effective in TP53 mutated myeloid tumors via overcoming differentiation block.

Decitabine with etoposide is effective in TP53 mutated myeloid tumors via overcoming differentiation block.

Journal: Blood cancer journal

Published: November 18, 2024

Mitoxantrone-Based Novel Conditioning Regimen Leads to Great Survival Benefit in Peripheral T-Cell Lymphoma Compared to BEAM Regimen.

Mitoxantrone-Based Novel Conditioning Regimen Leads to Great Survival Benefit in Peripheral T-Cell Lymphoma Compared to BEAM Regimen.

Journal: Cancer medicine

Published: October 09, 2024

Consolidation therapy with autologous stem cell transplantation after remission of induction chemotherapy prolongs the survival of patients with peripheral T-cell lymphoma.

Consolidation therapy with autologous stem cell transplantation after remission of induction chemotherapy prolongs the survival of patients with peripheral T-cell lymphoma.

Journal: Frontiers in immunology

Published: February 05, 2024

Nc-RNA-mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma.

Nc-RNA-mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma.

Journal: Cancer medicine

Published: January 17, 2024

Efficacy and safety of daratumumab in the treatment of relapsed/refractory multiple myeloma.

Efficacy and safety of daratumumab in the treatment of relapsed/refractory multiple myeloma.

Journal: Minerva pediatrics

Published: May 31, 2023

Maintenance regimen of GM-CSF with rituximab and lenalidomide improves survival in high-risk B-cell lymphoma by modulating natural killer cells.

Maintenance regimen of GM-CSF with rituximab and lenalidomide improves survival in high-risk B-cell lymphoma by modulating natural killer cells.

Journal: Cancer medicine

Published: November 24, 2022

Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL.

Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL.

Journal: Bone marrow transplantation

Published: March 25, 2022

Clinical characteristics and prognostic factors of lymphoma patients initially presenting with fever of unknown origin.

Clinical characteristics and prognostic factors of lymphoma patients initially presenting with fever of unknown origin.

Journal: American journal of translational research

Published: January 14, 2022

18F-fluorodeoxyglucose positron emission tomography-based prediction for splenectomy in patients with suspected splenic lymphoma.

18F-fluorodeoxyglucose positron emission tomography-based prediction for splenectomy in patients with suspected splenic lymphoma.

Journal: Annals of translational medicine

Published: April 27, 2021

Survival Benefit and Efficiency of Low Dose Decitabine With CEG Regimen Compared to Decitabine Alone in the Elderly MDS - A Multicenter, Retrospective Study.

Survival Benefit and Efficiency of Low Dose Decitabine With CEG Regimen Compared to Decitabine Alone in the Elderly MDS - A Multicenter, Retrospective Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 14, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026